Does VALGANCICLOVIR Cause Aplastic anaemia? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Aplastic anaemia have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 0.2% of all adverse event reports for VALGANCICLOVIR.
14
Reports of Aplastic anaemia with VALGANCICLOVIR
0.2%
of all VALGANCICLOVIR reports
7
Deaths
6
Hospitalizations
How Dangerous Is Aplastic anaemia From VALGANCICLOVIR?
Of the 14 reports, 7 (50.0%) resulted in death, 6 (42.9%) required hospitalization, and 5 (35.7%) were considered life-threatening.
Is Aplastic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does VALGANCICLOVIR Cause?
Off label use (1,882)
Cytomegalovirus infection (1,091)
Drug ineffective (886)
Neutropenia (809)
Leukopenia (574)
Drug resistance (524)
Cytomegalovirus viraemia (447)
Pancytopenia (434)
Cytomegalovirus infection reactivation (374)
Death (359)
What Other Drugs Cause Aplastic anaemia?
ECULIZUMAB (345)
CYCLOPHOSPHAMIDE (332)
CYCLOSPORINE (331)
METHOTREXATE (281)
BUSULFAN (220)
FLUDARABINE (220)
ETOPOSIDE (186)
VINCRISTINE (173)
CYTARABINE (163)
ELTROMBOPAG OLAMINE (149)
Which VALGANCICLOVIR Alternatives Have Lower Aplastic anaemia Risk?
VALGANCICLOVIR vs VALIUM
VALGANCICLOVIR vs VALPROATE
VALGANCICLOVIR vs VALPROIC ACID
VALGANCICLOVIR vs VALPROMIDE
VALGANCICLOVIR vs VALSARTAN